Cargando…
Glaucocalyxin A Attenuates Allergic Responses by Inhibiting Mast Cell Degranulation through p38MAPK/NrF2/HO-1 and HMGB1/TLR4/NF-κB Signaling Pathways
Glaucocalyxin A (GLA) has various pharmacological effects like antioxidation, immune regulation, and antiatherosclerosis. Here, in this study, the effect and mechanism of GLA on mast cell degranulation were studied. The results of the anti-DNP IgE-mediated passive cutaneous anaphylaxis (PCA) showed...
Autores principales: | , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8110394/ https://www.ncbi.nlm.nih.gov/pubmed/34007295 http://dx.doi.org/10.1155/2021/6644751 |
_version_ | 1783690293681324032 |
---|---|
author | Piao, Yihua Jiang, Jingzhi Wang, Zhiguang Wang, Chongyang Jin, Shan Li, Li Li, Liangchang Piao, Hongmei Jin, Zhehu Zhu, Lianhua Yan, Guanghai |
author_facet | Piao, Yihua Jiang, Jingzhi Wang, Zhiguang Wang, Chongyang Jin, Shan Li, Li Li, Liangchang Piao, Hongmei Jin, Zhehu Zhu, Lianhua Yan, Guanghai |
author_sort | Piao, Yihua |
collection | PubMed |
description | Glaucocalyxin A (GLA) has various pharmacological effects like antioxidation, immune regulation, and antiatherosclerosis. Here, in this study, the effect and mechanism of GLA on mast cell degranulation were studied. The results of the anti-DNP IgE-mediated passive cutaneous anaphylaxis (PCA) showed that GLA dramatically inhibited PCA in vivo, as evidenced by reduced Evans blue extravasation and decreased ear thickness. In addition, GLA significantly reduced the release of histamine and β-hexosaminidase, calcium influx, cytokine (IL-4, TNF-α, IL-1β, IL-13, and IL-8) production in the RBL-2H3 (rat basophilic leukemia cells), and RPMCs (peritoneal mast cells) in vitro. Moreover, we further investigated the regulatory mechanism of GLA on antigen-induced mast cells by Western blot, which showed that GLA inhibited FcεRI-mediated signal transduction and invalidated the phosphorylation of Syk, Fyn, Lyn, Gab2, and PLC-γ1. In addition, GLA inhibited the recombinant mouse high mobility group protein B1- (HMGB1-) induced mast cell degranulation through limiting nuclear translocation of NF-κBp65. Treatment of mast cells with siRNA-HMGB1 significantly inhibited HMGB1 levels, as well as MyD88 and TLR4, decreased intracellular calcium levels, and suppressed the release of β-hexosaminidase. Meanwhile, GLA increased NrF2 and HO-1 levels by activating p38MAPK phosphorylation. Consequently, these data suggest that GLA regulates the NrF2/HO-1 signaling pathway through p38MAPK phosphorylation and inhibits HMGB1/TLR4/NF-κB signaling pathway to reduce mast cell degranulation and allergic inflammation. Our findings could be used as a promising therapeutic drug against allergic inflammatory disease. |
format | Online Article Text |
id | pubmed-8110394 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Hindawi |
record_format | MEDLINE/PubMed |
spelling | pubmed-81103942021-05-17 Glaucocalyxin A Attenuates Allergic Responses by Inhibiting Mast Cell Degranulation through p38MAPK/NrF2/HO-1 and HMGB1/TLR4/NF-κB Signaling Pathways Piao, Yihua Jiang, Jingzhi Wang, Zhiguang Wang, Chongyang Jin, Shan Li, Li Li, Liangchang Piao, Hongmei Jin, Zhehu Zhu, Lianhua Yan, Guanghai Evid Based Complement Alternat Med Research Article Glaucocalyxin A (GLA) has various pharmacological effects like antioxidation, immune regulation, and antiatherosclerosis. Here, in this study, the effect and mechanism of GLA on mast cell degranulation were studied. The results of the anti-DNP IgE-mediated passive cutaneous anaphylaxis (PCA) showed that GLA dramatically inhibited PCA in vivo, as evidenced by reduced Evans blue extravasation and decreased ear thickness. In addition, GLA significantly reduced the release of histamine and β-hexosaminidase, calcium influx, cytokine (IL-4, TNF-α, IL-1β, IL-13, and IL-8) production in the RBL-2H3 (rat basophilic leukemia cells), and RPMCs (peritoneal mast cells) in vitro. Moreover, we further investigated the regulatory mechanism of GLA on antigen-induced mast cells by Western blot, which showed that GLA inhibited FcεRI-mediated signal transduction and invalidated the phosphorylation of Syk, Fyn, Lyn, Gab2, and PLC-γ1. In addition, GLA inhibited the recombinant mouse high mobility group protein B1- (HMGB1-) induced mast cell degranulation through limiting nuclear translocation of NF-κBp65. Treatment of mast cells with siRNA-HMGB1 significantly inhibited HMGB1 levels, as well as MyD88 and TLR4, decreased intracellular calcium levels, and suppressed the release of β-hexosaminidase. Meanwhile, GLA increased NrF2 and HO-1 levels by activating p38MAPK phosphorylation. Consequently, these data suggest that GLA regulates the NrF2/HO-1 signaling pathway through p38MAPK phosphorylation and inhibits HMGB1/TLR4/NF-κB signaling pathway to reduce mast cell degranulation and allergic inflammation. Our findings could be used as a promising therapeutic drug against allergic inflammatory disease. Hindawi 2021-04-30 /pmc/articles/PMC8110394/ /pubmed/34007295 http://dx.doi.org/10.1155/2021/6644751 Text en Copyright © 2021 Yihua Piao et al. https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Research Article Piao, Yihua Jiang, Jingzhi Wang, Zhiguang Wang, Chongyang Jin, Shan Li, Li Li, Liangchang Piao, Hongmei Jin, Zhehu Zhu, Lianhua Yan, Guanghai Glaucocalyxin A Attenuates Allergic Responses by Inhibiting Mast Cell Degranulation through p38MAPK/NrF2/HO-1 and HMGB1/TLR4/NF-κB Signaling Pathways |
title | Glaucocalyxin A Attenuates Allergic Responses by Inhibiting Mast Cell Degranulation through p38MAPK/NrF2/HO-1 and HMGB1/TLR4/NF-κB Signaling Pathways |
title_full | Glaucocalyxin A Attenuates Allergic Responses by Inhibiting Mast Cell Degranulation through p38MAPK/NrF2/HO-1 and HMGB1/TLR4/NF-κB Signaling Pathways |
title_fullStr | Glaucocalyxin A Attenuates Allergic Responses by Inhibiting Mast Cell Degranulation through p38MAPK/NrF2/HO-1 and HMGB1/TLR4/NF-κB Signaling Pathways |
title_full_unstemmed | Glaucocalyxin A Attenuates Allergic Responses by Inhibiting Mast Cell Degranulation through p38MAPK/NrF2/HO-1 and HMGB1/TLR4/NF-κB Signaling Pathways |
title_short | Glaucocalyxin A Attenuates Allergic Responses by Inhibiting Mast Cell Degranulation through p38MAPK/NrF2/HO-1 and HMGB1/TLR4/NF-κB Signaling Pathways |
title_sort | glaucocalyxin a attenuates allergic responses by inhibiting mast cell degranulation through p38mapk/nrf2/ho-1 and hmgb1/tlr4/nf-κb signaling pathways |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8110394/ https://www.ncbi.nlm.nih.gov/pubmed/34007295 http://dx.doi.org/10.1155/2021/6644751 |
work_keys_str_mv | AT piaoyihua glaucocalyxinaattenuatesallergicresponsesbyinhibitingmastcelldegranulationthroughp38mapknrf2ho1andhmgb1tlr4nfkbsignalingpathways AT jiangjingzhi glaucocalyxinaattenuatesallergicresponsesbyinhibitingmastcelldegranulationthroughp38mapknrf2ho1andhmgb1tlr4nfkbsignalingpathways AT wangzhiguang glaucocalyxinaattenuatesallergicresponsesbyinhibitingmastcelldegranulationthroughp38mapknrf2ho1andhmgb1tlr4nfkbsignalingpathways AT wangchongyang glaucocalyxinaattenuatesallergicresponsesbyinhibitingmastcelldegranulationthroughp38mapknrf2ho1andhmgb1tlr4nfkbsignalingpathways AT jinshan glaucocalyxinaattenuatesallergicresponsesbyinhibitingmastcelldegranulationthroughp38mapknrf2ho1andhmgb1tlr4nfkbsignalingpathways AT lili glaucocalyxinaattenuatesallergicresponsesbyinhibitingmastcelldegranulationthroughp38mapknrf2ho1andhmgb1tlr4nfkbsignalingpathways AT liliangchang glaucocalyxinaattenuatesallergicresponsesbyinhibitingmastcelldegranulationthroughp38mapknrf2ho1andhmgb1tlr4nfkbsignalingpathways AT piaohongmei glaucocalyxinaattenuatesallergicresponsesbyinhibitingmastcelldegranulationthroughp38mapknrf2ho1andhmgb1tlr4nfkbsignalingpathways AT jinzhehu glaucocalyxinaattenuatesallergicresponsesbyinhibitingmastcelldegranulationthroughp38mapknrf2ho1andhmgb1tlr4nfkbsignalingpathways AT zhulianhua glaucocalyxinaattenuatesallergicresponsesbyinhibitingmastcelldegranulationthroughp38mapknrf2ho1andhmgb1tlr4nfkbsignalingpathways AT yanguanghai glaucocalyxinaattenuatesallergicresponsesbyinhibitingmastcelldegranulationthroughp38mapknrf2ho1andhmgb1tlr4nfkbsignalingpathways |